📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]". (2021)

First Author: McCracken JT

Attributed to: MRC Centre for Neurodevelopmental Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.euroneuro.2021.07.090

PubMed Identifier: 34348215

Publication URI: http://europepmc.org/abstract/MED/34348215

Type: Journal Article/Review

Volume: 50

Parent Publication: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

ISSN: 0924-977X